Parecoxib and postoperative shivering in patients undergoing general anesthesia.

Parecoxib and postoperative shivering in patients undergoing general anesthesia. - Parecoxib and shivering

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008532

Enrollment

Registered

2012-07-25

Start date

2012-07-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients undergoing general anesthesia were recruited into the study

Interventions

In group P, intravenous parecoxib (40mg) was given following the induction of anesthesia. In group S, patients recived the same amount of saline 0.9% infusion.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: adult patients (ASA physical status I or II) scheduled for elective minor urological surgery under general anesthetic with no prior medication were included in this study

Exclusion criteria

Exclusion criteria: 1, initial body temperature more than 38 centigrade or less than 36.5 centigrade; 2, hyperthyroidism, hypertension, diabetes mellitus, impaired renal or liver functions, endocrine or cardiopulmonary disease; 3, taking vasoactive or antidepressant drugs, receiving intraoperative blood or blood products transfusion; 4, known history of alcohol or substance abuse, or possible pregnancy;

Design outcomes

Primary

Measure	Time frame
the overall incidence and grades of postoperative shivering	—

Countries

Asia(except Japan)

Contacts

Public ContactChen Jie

Third Military Medical University Department of Anaesthesiology, Southwest Hospital,

cjandsh2009@yahoo.cn+81-086-23-68754197

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026